XML 20 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Fair Value Measurements and Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Fair Value of Financial Instruments

3. Fair Value Measurements and Fair Value of Financial Instruments

The authoritative guidance on the fair value hierarchy for disclosure of fair value measurements is as follows:

Level 1: Quoted prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The fair value of Level 1 securities is determined using quoted prices in active markets for identical assets. Level 1 securities consist of highly liquid money market funds. Financial assets and liabilities are considered Level 2 when their fair values are determined using inputs that are observable in the market or can be derived principally from or corroborated by observable market data such as pricing for similar securities, recently executed transactions, cash flow models with yield curves, and benchmark securities. In addition, Level 2 financial instruments are valued using comparisons to like-kind financial instruments and models that use readily observable market data as their basis. U.S. government and agency securities, commercial paper, corporate bond and certificates of deposit are valued primarily using market prices of comparable securities, bid/ask quotes, interest rate yields and prepayment spreads and are included in Level 2. In certain cases, where there is limited activity or less transparency around inputs to valuation, securities are classified as Level 3 within the valuation hierarchy.

The following is a summary of the Company’s cash equivalents and short-term investments:

 

 

 

June 30, 2019

 

 

 

Amortized

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Loses

 

 

Estimated

Fair Value

 

 

 

(In thousands)

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

44

 

 

$

 

 

$

 

 

$

44

 

Level 2:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agency securities

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

 

147,334

 

 

 

7

 

 

 

(22

)

 

 

147,319

 

Corporate bonds

 

 

25,304

 

 

 

25

 

 

 

(2

)

 

 

25,327

 

Total cash equivalents and

   short-term investments

 

 

172,682

 

 

 

32

 

 

 

(24

)

 

 

172,690

 

Less: cash equivalents

 

 

(92,871

)

 

 

 

 

 

15

 

 

 

(92,856

)

Total short-term investments

 

$

79,811

 

 

$

32

 

 

$

(9

)

 

$

79,834

 

 

 

 

December 31, 2018

 

 

 

Amortized

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Loses

 

 

Estimated

Fair Value

 

 

 

(In thousands)

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

126

 

 

$

 

 

$

 

 

$

126

 

Level 2:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agency securities

 

 

25,792

 

 

 

1

 

 

 

(4

)

 

 

25,789

 

Commercial paper

 

 

147,606

 

 

 

 

 

 

 

 

 

147,606

 

Corporate bonds

 

 

27,778

 

 

 

5

 

 

 

(17

)

 

 

27,766

 

Certificates of deposit

 

 

1,420

 

 

 

 

 

 

 

 

 

1,420

 

Total cash equivalents and

   short-term investments

 

 

202,722

 

 

 

6

 

 

 

(21

)

 

 

202,707

 

Less: cash equivalents

 

 

(152,577

)

 

 

 

 

 

 

 

 

(152,577

)

Total short-term investments

 

$

50,145

 

 

$

6

 

 

$

(21

)

 

$

50,130

 

 

There were no transfers within the fair value hierarchy during the three and six months ended June 30, 2019 or 2018.

The Company’s marketable securities as of June 30, 2019 mature within one year. Management regularly reviews all of the Company’s investments for other-than-temporary declines in estimated fair value. Management’s review includes the consideration of the cause of the impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether management has the intent to sell the securities and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their amortized cost basis. Management determined that the gross unrealized losses on the Company’s marketable securities as of June 30, 2019 were temporary in nature. Therefore, none of the Company’s marketable securities were other-than-temporarily impaired as of June 30, 2019.